Table 3.
Estimated values of fixed effects (arterial load and cardiac parameters) on Eadyn according to a linear mixed-effects model analysis.
| Covariates | Eadyn | p |
|---|---|---|
| Arterial covariates | ||
| SAP (mmHg) | −0.02 (0.01) | 0.040 |
| DAP (mmHg) | −0.03 (0.01) | 0.040 |
| MAP (mmHg) | −0.03 (0.01) | 0.030 |
| PP (mmHg) | 0.19 (0.04) | 0.190 |
| CCP (mmHg) | −0.55 (0.02) | 0.020 |
| SARi (mmHg ml−1·m−2) | −0.11 (0.04) | 0.730 |
| EA (mmHg ml−1·m−2) | −0.43 (0.22) | 0.070 |
| CA (ml mmHg−1·m−2) | 1.25 (0.33) | 0.010 |
| TPRi (mmHg ml−1·m−2) | −0.05 (0.02) | 0.020 |
| Norepinephrine dose (g kg−1 min−1) | −5.9 (3.3) | 0.090 |
| Cardiac covariates | ||
| HR (beats min−1) | −0.01 (0.01) | 0.230 |
| LVEF (%) | 0.016 (0.011) | 0.670 |
| EV (mmHg ml−1·m−2) | −0.17 (0.22) | 0.330 |
| EA/EV (units) | −0.10 (0.038) | 0.610 |
| CI (l min−1·m−2) | 0.89 (0.36) | 0.020 |
Data are presented as an estimated value (SE). CA, arterial compliance; CI, cardiac index; CVP, central venous pressure; DAP, diastolic arterial pressure; EA, arterial elastance; Eadyn, dynamic arterial elastance; EV, ventricular elastance; NE, norepinephrine; HR, heart rate; LVEF, left ventricular ejection fraction; MAP, mean arterial pressure; MSP, mean systemic pressure; CCP, critical closing pressure; PP, pulse pressure; TPRi, indexed total peripheral resistance; SAP, systolic arterial pressure; SARi, indexed systemic arterial resistance. Bold values are values with p < 0.05.